Aims: To evaluate pharmacoeconomics for the vaccination of COVID-19 vaccine and analyze the cost-effectiveness for the vaccine in Ukraine. Study design:  we have analyzed using models for the economics of coronavirus vaccine. Place and duration of study: Sample: population of Ukraine, data used from the official website of Ministry of Health, Ukraine. April - May 2021 Methodology: We have used the transmission model to analyze the vaccine strategy. Data were collected from official sources. We structured an age group model for evaluating high transmitters. Four strategies were organized and analyzed for analyzing the cost-effective strategy vaccination for everyone, no vaccination, and vaccination for old age only, high transmitters’ vaccination. Results: we have analyzed country specific cost-effective strategy for Ukraine depends upon the pandemic and economics of the country. Vaccinating older people was found to be the economically effective for Ukraine. In these study influences of discount rate analysis on QALY in Ukraine was done. When we vaccinate, high transmitters’ ratio was found to be 8.8% higher than for the elderly. This analysis suggests that vaccinating first the elderly group would not be so cost-effective. While doubling the cost for the vaccine, if the vaccine is available early with the scenario of pre-existing immunity has shifted cost-effectiveness for high transmitters than for the elderly in Ukraine Conclusion: we conclude from our pharmacoeconomic research study that cost effective analysis depends on pandemic and vaccinating elderly would be effective economically.

No abstract

Aim: Pharmaceutical healthcare is a process comprising knowledge-intensive tasks. Therefore the tools used in the management of knowledge are gaining more attention. This paper aims to investigate knowledge management systems, their implementation, tools used for decision making. Method: We have used three databases to research the knowledge management system in the pharmaceutical healthcare sector. PubMed, Google Scholar and journal websites were used for the search of the required key terms. Result: After analyzing the data, it was found that the effective utilization of knowledge management systems in the pharmaceutical health care sector has increased the quality of care. There are many opportunities; some create new advances in health care, and some even create barriers. All these help in clinical decision support. Conclusion: Right decision at the right time is made by evidence-based decisions in the healthcare sector. A knowledge management system is paramount in the pharmaceutical healthcare sector. Implementation of appropriate tools will significantly enhance the quality of care.

Aims: There is an increase in demand for the social environment regulations in the pharmaceutical companies, which is a crucial strategy issue in long-term planning due to the incidence of social influence. The influence of society over resource allocation and its control over innovation is all the perceptions of today's needs. This research aims to highlight the managerial issues faced by the pharmaceutical healthcare sector of Ukraine. Our study is unique as we have analyzed the whole pharmaceutical sector of Ukraine in terms of management issues. There is no such research done yet. In addition, we have also researched the official databases and laid down the models for management practices. Methodology: The research was done to analyze the major issues in the social management of the pharmaceutical healthcare system. In addition, the related studies based on managerial issues were studied. The following databases were used to study the guidelines: World Health Organisation, Food and Drug Administration, Internationational Council for Harmonization, and European Union. Results: The results were found to be when comparing behavioural studies with non-behavioural; non-behavioural was found to be 64%, whereas behavioural was 34%. To have an in-depth knowledge of the managerial issues, we have provided an inverted tree diagram representing the significant issues in pricing and medical expenditures. These contributed 21.7% of non-behavioural studies, and in behavioural studies, it was found to be consumer or physician-level behaviour 23.4% contributing the central part of the issue.   Conclusion: Here we conclude that the pharmaceutical healthcare sector plays a crucial role in the global healthcare of the general public-facing management issues; hence should be analyzed and follow the guidelines to analyze the issues within the company and set goals.    Therefore, improving the management of the pharma sector will, in turn, improve public health in Ukraine.